Literature DB >> 10924712

S-nitroso-l-cysteine releases norepinephrine in rat spinal synaptosomes.

X Li1, G Rose, N Dongre, H L Pan, J R Tobin, J C Eisenach.   

Abstract

Although nitric oxide (NO) participates in development of hypersensitivity states in the spinal cord thought to underlie chronic pain, it also participates in analgesia produced by various drugs. In rats with a hypersensitivity state following peripheral nerve injury, spinal administration of an NO donor or l-cysteine alone produced no effect, whereas their combination, which yields s-nitroso-l-cysteine (SNC) powerfully reduced hypersensitivity. In the current study, we examined the ability of SNC to stimulate release of a known spinal analgesic neurotransmitter, norepinephrine (NE), as a possible mechanism of analgesic action of NO in the spinal cord. SNC (but not the NO donor alone or decomposed SNC) produced a concentration-dependent release of NE from rat spinal cord synaptosomes. The d-isomer of SNC was less potent than the l-isomer, and the effect of SNC was partially blocked by l-, but not d-leucine, implicating an interaction with the l-amino acid transporter. SNC-induced NE release was partially Na(+) dependent, but largely Ca(2+) independent. NE uptake inhibitors partially antagonized the effect of SNC, but guanylate cyclase inhibitors were without effect. These data are therefore consistent with NO stimulating NE release in the spinal cord via reaction with thiol containing compounds, such as cysteine, entry into NE terminals via active transport, and production of both exocytotic and carrier mediated release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924712     DOI: 10.1016/s0006-8993(00)02551-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Neuronal nitric oxide synthase is upregulated in a subset of primary sensory afferents after nerve injury which are necessary for analgesia from alpha2-adrenoceptor stimulation.

Authors:  Weiya Ma; James C Eisenach
Journal:  Brain Res       Date:  2006-11-17       Impact factor: 3.252

2.  Nitric oxide selectively tunes inhibitory synapses to modulate vertebrate locomotion.

Authors:  David L McLean; Keith T Sillar
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

3.  S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Ryan B Gruber; Benjamin Gaston; Tristan H J Lewis; Alan Grossfield; James M Seckler; Yee-Hsee Hsieh; James N Bates; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

4.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

5.  S-nitroso-L-cysteine stereoselectively blunts the adverse effects of morphine on breathing and arterial blood gas chemistry while promoting analgesia.

Authors:  Paulina M Getsy; Alex P Young; James N Bates; Santhosh M Baby; James M Seckler; Alan Grossfield; Yee-Hsee Hsieh; Tristan H J Lewis; Michael W Jenkins; Benjamin Gaston; Stephen J Lewis
Journal:  Biomed Pharmacother       Date:  2022-07-26       Impact factor: 7.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.